Daniel W. Hunt - Net Worth and Insider Trading

Daniel W. Hunt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel W. Hunt owns 1 companies in total, including Corvus Pharmaceuticals Inc (CRVS) .

Click here to see the complete history of Daniel W. Hunt’s form 4 insider trades.

Insider Ownership Summary of Daniel W. Hunt

Ticker	Comapny	Transaction Date	Type of Owner
CRVS	Corvus Pharmaceuticals Inc	2017-12-13	SVP & Chief Business Officer

Daniel W. Hunt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel W. Hunt Ownership Network

Ownership Network List of Daniel W. Hunt

No Data

Ownership Network Relation of Daniel W. Hunt

Daniel W. Hunt Owned Company Details

What does Corvus Pharmaceuticals Inc do?

Who are the key executives at Corvus Pharmaceuticals Inc?

Daniel W. Hunt is the SVP & Chief Business Officer of Corvus Pharmaceuticals Inc. Other key executives at Corvus Pharmaceuticals Inc include director & President and CEO Miller Richard A Md , See Remarks William Benton Jones , and Chief Financial Officer Leiv Lea .

Corvus Pharmaceuticals Inc (CRVS) Insider Trades Summary

Over the past 18 months, Daniel W. Hunt made no insider transaction in Corvus Pharmaceuticals Inc (CRVS). Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net purchase of 577,634 shares made by Miller Richard A Md , a net purchase of 20,000 shares made by William Benton Jones , and a net purchase of 10,000 shares made by Linda S Grais .

In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 607,634 shares were bought by its insiders, resulting in a net purchase of 607,634 shares.

Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Corvus Pharmaceuticals Inc Insider Transactions

No Available Data

Daniel W. Hunt Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel W. Hunt. You might contact Daniel W. Hunt via mailing address: 863 Mitten Road, Suite 102, Burlingame Ca 94010.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.